Indivior (INDVL)

1,024.00p
   
  • Change Today:
      0.090p
  • 52 Week High: 1,311.00
  • 52 Week Low: 577.50
  • Currency: UK Pounds
  • Shares Issued: 718.58m
  • Volume: 33,461
  • Market Cap: £7,358m

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Key Personnel

CEO: Mark Crossley
Chairman: David E. Wheadon
Independent Non-Executive Director: Mark Stejbach
Independent Non-Executive Director: Peter Bains
Independent Non-Executive Director: Joe Ciaffoni
Independent Non-Executive Director: Barbara Ryan
Independent Non-Executive Director: Daniel A. Ninivaggi
Independent Non-Executive Director: Keith Humphreys
Independent Non-Executive Director: Jo Le Couilliard
Senior Independent Director: Juliet Thompson
Non-Executive Dir:

Contact Details

Address: 234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE
Website: http://www.Indivior.com

Listings

Overseas Listings: LSE:INDV
ISIN: GB00BRS65X63

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

Indivior Market Data

Currency UK Pounds
Share Price 1,024.00p
Change Today 0.090p
% Change 0.89 %
52 Week High 1,311.00
52 Week Low 577.50
Volume 33,461
Shares Issued 718.58m
Market Cap £7,358m

Trades for 24-Jun-2025

Time Volume / Share Price
16:29 98 @ 1,024.00p
16:29 58 @ 1,024.00p
16:29 17 @ 1,024.00p
16:29 14 @ 1,021.00p
16:29 6 @ 1,022.00p

Indivior Key Personnel

CEO Mark Crossley
Chair David E. Wheadon

Top of Page